Revascularisation for chronic heart failure: A valid option?

European Journal of Heart Failure

Volumn 1, Issue 3, 1999, Pages 269-273

  Pagano, D ^a   Camici, P G ^b   Bonser, R S ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary heart disease; Heart failure; Hibernating myocardium

Indexed keywords

ANGINA PECTORIS; ARTICLE; CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; SURVIVAL; SYMPTOMATOLOGY;

CORONARY ARTERY BYPASS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033494414     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(99)00036-7     Document Type: Article

References (35)

1. Teerlink J., Goldhaber S., Pfeffer M. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 121:1991;1852-1853.
2. Alderman E., Fisher L., Litwin P. et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 4:1983;785-795.
3. Bounous EP, Mark DB, Pollock BG, et al. Surgical survival benefit for coronary disease patients with left ventricular dysfunction. Circulation 1988; 78 (Suppl. I): I-151-I-157.
4. Wechsler AS, Junod FL. Coronary bypass grafting in patients with chronic congestive heart failure. Circulation 1989; 79 (Suppl I); I-92-I-96.
5. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina. Circulation 1985; 72 (Suppl V); V-123-V-135.
6. Braunwald E., Rutherford J. Reversible ischaemic left ventricular dysfunction: evidence for 'hibernating myocardium'. J Am Coll Cardiol. 8:1986;1467-1470.
7. Pagano D., Townend J., Horton R., Littler W., Camici P.G., Bonser R.S. Coronary artery bypass grafting for ischemic heart failure. The predictive value of quantitative PET for symptomatic and functional outcome. J Thorac Cardiovasc Surg. 115:1998;791-799.
8. Edmond M. and Participants in the C.A.S.S. (CASS), Long-term survival of medically treated patients in the coronary artery surgery study (CASS). Circulation. 90:1994;2645-2657.
9. Arnese M., Cornel J., Salustri A. et al. Prediction of improvement of regional left ventricular function after surgical revascularisation. A comparison of low-dose dobutamine echocardiography with 201-Tl single photon emission computed tomography. Circulation. 91:1995;2748-2752.
10. Bax J., Cornel J., Visser F. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 Fluorodeoxyglucose/Thallium SPECT. Thallium-201 Stress-reinjection and dobutamine echocardiography. J Am Coll Cardiol. 28:1996;558-564.
11. Wijns W., Vatner S., Camici P.G. Hibernating myocardium. N Engl J Med. 339:1998;173-181.
12. Gerber B., Vanovershelde J.-L., Bol A., Michel C., Labar D., Wijns W., Melin J. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation. 94:1996;651-659.
13. vom Dahl J., Eitzman D.T., al Aouar Z.R. et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 90:1994;2356-2366.
14. Bonow R. Identification of viable myocardium. Circulation. 94:1996;2674-2678.
15. Pagano D., Bonser R.S., Townend J., Ordoubadi F., Lorenzoni R., Camici P.G. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart. 79:1998;281-288.
16. Perrone-Filardi P., Pace L., Prastraro M. et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201-Thallium tomography versus dobutamine echocardiography. Circulation. 94:1996;2712-2719.
17. Pagano D., Bonser R.S., Townend J., Parums D., Camici P.G. Histopathological correlates of dobutamine echocardiography in hibernating myocardium (Abstract). Circulation. 94(Suppl I):1996;231.
18. Louie H, Laks H, Milgalter E, et al. Ischaemic cardiomyopathy. Criteria for myocardial revescularisation and cardiac transplantation. Circulation 1991; 86 (Suppl III): III-290-III-295.
19. Luciani G.B., Faggian G., Razzolini R., Livi U., Bortolotti U., Mazzucco A. Severe ischaemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg. 55:1993;719-723.
20. Milano C.A., White W.D., Smith L.R. et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg. 56:1993;487-493.
21. Mickleborough L, Maruyama H, Tagaki T, Mohamed S, Sun Z, Ebisuzaki L. Results of revascularisation in patients with severe left ventricular dysfunction. Circulation 1995; 92 (Suppl II): II-73-II-79.
22. Dreyfus G., Duboc D., Blasco A. et al. Myocardial viability assessment in ischaemic cardiomyopathy: benefits of coronary revascularisation. Ann Thorac Surg. 57:1994;1402-1408.
23. Pagley P., Beller G., Watson D., Gimple L., Ragosta M. Improved outcome after coronary artery bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 96:1997;793-800.
24. DiCarli M., Sherman T., Khanna S. et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;860-868.
25. Cohn J., Johnson G., Ziesche S. et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
26. Eitzman D., Aouar Z.A., Kanter H.L. et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography (see comments). J Am Coll Cardiol. 20:1992;559-565.
27. Lee S., Marwick T., Cook S. et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularisation. Circulation. 90:1994;2687-2694.
28. Pagano D, Lewis ME, Townend J, Camici PG, Bonser RS. Revascularisation for post-ischaemic heart failure: how myocardial viability affects survival. Heart 1999:in press (Abstract).
29. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med. 316:1987;1429-1435.
30. Townend J., Littler W. Angiotensine converting enzyme inhibitors in heart failure: how good are they? Br Heart J. 5:1993;373-376.
31. Faulkner S., Stoney W., Alford W. et al. Ischaemic cardiomyopathy medical versus surgical treatment. J Thorac Cardiovasc Surg. 74:1977;77-82.
32. Kron I.L., Flanagan T.L., Blackbourne L.H., Schroeder R.A., Nolan S.P. Coronary revascularization rather than cardiac transplantation for chronic ischaemic cardiomyopathy. Ann Surg. 210:1989;348-354.
33. Elefteriades J.A., Tolis G. Jr, Levi E., Mills L.K., Zaret B.L. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 22:1993;1411-1417.
34. Lansman S., Cohen M., Galla J. et al. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long term follow-up. Ann Thorac Surg. 56:1993;480-486.
35. Gunning M., Chua T., Harringhton D. et al. Hibernating myocardium: clinical and functional response to revascularisation. Eur J Cardio-thorac Surg. 11:1997;1105-1112.